refrigerator, you can store it at room temperature up to a maximum of 77 degrees F (25 degrees C) for a period of up to 14 days. Once your Humira Pen or prefilled syringe has reached room temperature, it must be used within 14 days even if it is put back in the refrigerator....
WHAT PFIZER BIOSIMILARS ARE AVAILABLE? Explore Pfizer's portfolio of biosimilars LEARN MORE BIOSIMILARS BY THE NUMBERS Potential 25+ biologic products Over 100 biologic products were expected to have lost patent or other protections by 2022, with additional products’ patents expiring in upcoming years...
The article focuses on the regulatory standards for approving biosimilar wherein a draft guidance was released by the U.S. Food and Drug Administration (FDA). According to Rachel Sherman of the FDA's Center for Drug Evaluation and Research, there are 35 pre-investigational new drug (IND) ...
Contact us Your source for biosimilars As one of the largest healthcare distributors in the United States (U.S.), Cardinal Health has broad access to commercially available biosimilars, as well as a deep understanding of the clinical and economic complexities related to biosimilars and their refere...
FDA Guides the Way to Biosimilars in the US.The article offers the author's insights on the implications of the draft guidance from the U.S. Food and Drug Administration (USFDA) for the healthcare industry on how to get biosimilar products. She says that the draft provides documents for ...
An up-to-date resource showing all biosimilars approved in the US as well as biosimilar applications filed with FDA, based on public records. Updated frequently, the number of biosimilars approved for marketing has risen markedly, while the biosimilars l
A recent analysis comparing biosimilar prices in the United States, Switzerland, and Germany found that biosimilars cost 2.74 times more in the US than in Switzerland and 1.94 times more compared to Germany.
We’re committed to improving access by making more biosimilars available. Learn about the difference biosimilars could make to the health care system. How Biosimilars HelpReferences: 1. Stark A. Remarks from FDA Commissioner Scott Gottlieb, M.D., as prepared for delivery at the Brookings ...
OncLive: It was recently announced that biosimilars for bevacizumab, rituximab, and trastuzumab will become available in the United States at a significant discount. How will this impact treatment decisions? Brufsky: Most of us will probably use the biosimilar. It's going to be imposed on us by...
The Chinese biosimilar industry has demonstrated rapid growth in recent years. Limited evidence is available about biosimilar uptake at the national level. This study aimed to assess biosimilar uptake in the case of trastuzumab and to explore potential f